Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Net Margin (2016)

Historic Net Margin for Rocket Pharmaceuticals (RCKT) over the last 1 years, with Q4 2016 value amounting to 4248.95%.

  • Rocket Pharmaceuticals' Net Margin changed N/A to 4248.95% in Q4 2016 from the same period last year, while for Sep 2017 it was 1824.19%, marking a year-over-year change of. This contributed to the annual value of 1750.98% for FY2015, which is 8648500.0% up from last year.
  • According to the latest figures from Q4 2016, Rocket Pharmaceuticals' Net Margin is 4248.95%.
  • Rocket Pharmaceuticals' Net Margin's 5-year high stood at 4917.22% during Q1 2016, with a 5-year trough of 2119.62% in Q3 2016.